Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine Augmentation in Antidepressant Nonresponders
NCT00344682Phase 4Completed
- Sponsor
- University of Massachusetts
- Start
- Jun 2006
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in major depressive disorder (MDD), sponsored by University of Massachusetts. Started Jun 2006; status: completed.
02
Drugs
memantine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00344682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00344682.